Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:24 PM
Ignite Modification Date:
2025-12-24 @ 11:24 PM
NCT ID:
NCT03515356
Eligibility Criteria:
Inclusion Criteria:
* Diagnosed GI cancer (e.g, colorectal, gastric, pancreatic, esophageal, bowel);
* Scheduled to receive at least 6 cycles of oxaliplatin (85 mg/m2);
* Receiving care at the University of Michigan or St. Joseph Cancer Clinics;
* A Karnofsky Performance Status ≥ 80% or an Eastern Cooperative Oncology Group Status 0 to 1;
* Voluntarily consented to participate in all intervention components.
Exclusion Criteria:
* Exercise- or mobility-limiting cardiovascular, pulmonary, musculoskeletal, or psychological disease, based on the EMR (electronic medical record) past medical history and consultation with the medical oncologist;
* Scheduled major surgery during the study time period;
* Pre-existing peripheral neuropathy prior to chemotherapy (potentially due to diabetes, central nervous system malignancy, vitamin deficiency, heredity, nerve compression injury, non-surgically corrected carpal tunnel disease, or alcohol dependence) per patient self-report in response to brief screening questions noted in the pre-screening section;
* Pregnancy;
* Inability to read or speak English;
* Prognosis of less than three months.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03515356
Study Brief:
Protocol Section:
NCT03515356